| Literature DB >> 29478016 |
Stergiani Tsoli1, Stephen Sutton2, Aikaterini Kassavou2.
Abstract
OBJECTIVE: A number of promising automated behaviour change interventions have been developed using advanced phone technology. This paper reviewed the effectiveness of interactive voice response (IVR)-based interventions designed to promote changes in specific health behaviours.Entities:
Keywords: behaviour change; interactive voice response; systematic review
Mesh:
Year: 2018 PMID: 29478016 PMCID: PMC5855236 DOI: 10.1136/bmjopen-2017-018974
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1PRISMA flow chart of screening process. IVR, interactive voice response; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses; RCT, randomised controlled trials.
Summary of study characteristics
| Author(s) | Setting and country | Sample characteristics at randomisation | Behaviour | Intervention characteristics | Duration | Outcome measurements |
| Andersson, | University, Sweden | n=708 | Alcohol consumption | Intervention: | Follow-up assessment: 6 weeks | *Alcohol Use Disorders Identification Test, and 16-item Daily Drinking Questionnaire |
| Cizmic | Kaiser Permanente, USA | n=246 | Medication adherence for osteoporosis (oral bisphosphonate) | Intervention: 1 outbound IVR call of average duration of 145–109 seconds. A letter was sent 7 days after the call to those patients who had not refilled their medications. | Follow-up assessment: 25 days after enrolment and at 6 months for those not meeting the 25 outcome | Medication Possession Ratio |
| Derose | Kaiser Permanente, USA | n=5216 | Medication adherence for CVDs (statins) | Intervention: outbound call, 1–2 weeks after the prescription date, letters were sent 1 week after the call to those patients who had not refilled their medications. | Follow-up assessment: 25 days from randomisation and initiation of telephone calls | Number of dispensation at three intervals in the following to randomisation year, collected by electronic pharmacy records. |
| Estabrooks | Kaiser Permanente, USA | n=77 | Physical activity, diet | Intervention: 1outbound IVR call per week. Each call lasted 5–10 min and targeted physical activity or diet | Follow-up assessment: 3 months | Physical activity: *Actigraph accelerometer for physical activity (moderate and vigorous) and rapid assessment physical activity scale. |
| Helzer | Primary care clinics, | n=348 | Alcohol consumption | Intervention: participants made the calls to the IVR system daily (inbound calls). The duration of each call decreased the first month of calling, reaching a mean of approximately 2 min | Follow-up assessment: 6 months | *The Timeline Follow Back (TLFB) tool |
| King | Community level, USA | n=145 | Physical activity | Intervention: | Follow-up assessment at 6 months | *Stanford 7 day physical activity recall, and Community Healthy Activities Model Program for Seniors questionnaire, and accelerometer for max 7 days for 26% of study randomly selected participants. |
| Migneault | Hospital and community health centres, USA | n=337 | Physical activity | Intervention: 1outbound call per week for 32 weeks. From those 12 calls included messages for physical activity; 9 calls included messages for diet consumption and 8 call included messages for medication adherence. | Follow-up assessment: 8 months | Physical activity: *Structured interview 7 Day PAR (subscale minutes per week), and accelerometer for max 7 days (for 48 randomly selected participants). |
| Rose | Community, USA | n=158 | Alcohol consumption | Intervention: daily outbound calls, with subsequent inbound calls. | Follow-up assessment: 4 months | TLFB tool (drinks per week). |
| Rose | Primary care, USA | n=1855 | Alcohol consumption | Intervention: single IVR call | Follow-up assessment: end of intervention. Duration of the IVR intervention: Uncl | TLFB tool (drinks per week). |
| Sherrard | University of Ottawa Heart Institute (UOHI), Canada | n=331 | Medication adherence for CVDs (discharged postsurgery medications) | Intervention: 11 outbound IVR call in predetermined time for the duration of the intervention | Follow-up assessment: 6 months | Self-reported (single item: remained or not on medication) |
| Sherrard | Hospital in Ontario, Canada | n=1608 | Medication adherence for coronary syndrome | Intervention: 5 outbound IVR calls in predetermined time between 10:00 and 12:00, 15:00–17:00 or 18:00–20:00, for the duration of the intervention. | Follow-up assessment: 12 months | Self-reported (single item: remained or not on medication). |
| Shet | Two ambulatory clinics and one private HIV clinic, India | n=631 | Medication adherence for HIV (ART) | Intervention: 1outbound and interactive IVR call per week in predetermined time and weekly non-interactive calls 4 days after the IVR call | Follow-up assessment: 24 months | Pill count measured by researcher. |
| Stacy | Large health benefits company, USA | n=578 | Medication adherence for CVDs (statins) | Intervention: 3outbound IVR calls | Follow-up assessment: 6 months | Point prevalence adherence collected by electronic medical records. |
| Vollmer | Kaiser Permanente, USA | n=8517 | Medication adherence for asthma (ICS) | Intervention: each participant received 1 of the 3 outbound IVR call types, each call lasted 2–3 minutes | Follow-up assessment: 18 months | Modification of the Medication Possession Ratio, collected by electronic medical records. |
| Vollmer | Kaiser Permanente, USA | n=14 502 | Medication adherence for CVD (statins) | IVR group: outbound IVR calls when due or overdue for refill medications. | Follow-up assessment: 12 months | Modification of the Proportion of Days Covered collected by electronic medical records. |
*Outcome measures included in the meta-analysis.
ART, antiretroviral treatment; C, comparator group; CVDs, cardiovascular diseases; F, female; I, Intervention group; ICS, inhaled corticosteroids; M, male; Uncl, unclear information.
Risk of bias of included studies by behaviour
| Author, year | Random sequence generation | Allocation concealment | Blinding of participants, personnel and outcome assessors | Incomplete outcome data | Selective reporting | Objective outcome assessment | Other bias |
| Alcohol consumption | |||||||
| Andersson, | ? | ? | − | + | + | − | ? |
| Helzer | ? | ? | − | + | − | − | ? |
| Rose | ? | ? | − | ? | ? | − | + |
| Rose | + | ? | + | ? | ? | − | + |
| Medication adherence | |||||||
| Cizmic | + | ? | − | + | ? | + | + |
| Derose | + | ? | − | + | ? | + | + |
| Migneault | + | ? | − | ? | ? | − | + |
| Sherrard | ? | + | − | + | − | − | + |
| Sherrard | + | ? | − | − | ? | − | + |
| Shet | ? | + | − | + | ? | + | + |
| Stacy | ? | ? | − | + | ? | + | + |
| Vollmer | ? | ? | − | + | ? | + | + |
| Vollmer | + | ? | − | + | ? | + | + |
| Diet | |||||||
| Estabrooks, | ? | ? | − | + | ? | − | ? |
| Migneault | + | ? | − | ? | ? | − | + |
| Physical activity | |||||||
| Estabrooks, | ? | ? | − | + | ? | + | ? |
| King | + | ? | − | + | ? | − | + |
| Migneault | + | ? | − | ? | ? | − | + |
Note: ‘+’ indicates low risk of bias; ‘−’ indicates high risk of bias; ‘?’ indicates unclear risk of bias.
Figure 2Forest plots of the Hedges’ g (95% CI) for alcohol, diet and physical activity interventions and OR (95% CI) for the medication adherence interventions. Differences are presented between the intervention and a comparator condition.
Figure 3Funnel plot of precision against Hedges’ g.